Highlights:
Order book up 21% since start of the year (excluding acquisitions and joint ventures)
Adjusted operating profit* up 7.0% to £20.0 million (2014: £18.7 million) and operating margins up from 10.7% to 12.1%
Reported revenue down 5.8% to £164.8 million (2014: £175.0 million)
Adjusted EPS* up 1.9% to 21.3 pence (2014: 20.9 pence)
Nanotechnology Tools and Service sectors performed well. Difficult trading environment for Industrial Products sector
Cost reduction programme delivering planned savings
MIR Acquisition and Scienta-Omicron joint venture performing as expected
Good cash performance with inflow before acquisitions and dividends of £1.4m (2014: £9.2m outflow)
Proposed half year dividend of 3.7 pence (2014: 3.7 pence)
